Companion Animal Vaccines Market: Strong Pipeline to Rapidly Surge Growth

Posted by Ganesh Shinde on January 5th, 2023

The global market for companion animal vaccines is being driven by the remarkable increase in companion animal ownership, as well as the rapid development of veterinary healthcare infrastructure.

The global Companion Animal Vaccines Market is expected to exceed US$ 2.5 billion in revenue in 2021, with a healthy CAGR of 2022-2029.

The measurable rise in the prevalence of zoonotic diseases will continue to drive demand for companion animal vaccines and drugs.

FDA approvals for novel and innovative companion animal vaccines continue to present opportunities for growth in companion animal vaccine research and development.

For example, Zoetis received regulatory approval for ProHeart, which is used to prevent Dirofilaria immitis heartworm disease in dogs.

Increasing R&D Investments to Widen Market Growth Prospects

Elanco, Ceva Sante Animale, and Boehringer Ingelheim are among the market leaders in companion animal vaccines.

These companies continue to dominate the companion animal vaccine market by heavily investing in R&D activities to develop and launch therapeutic vaccines for the prevention and treatment of various animal diseases.

Increased investment in vaccine R&D, which inhibits the growth of antibiotic-resistant organisms, propels the animal vaccines market forward.

For example, in August 2018, Elanco invested two-thirds of its budget in the foodanimal unit to develop vaccines and reduce antibiotic use.

Furthermore, the increased demand for animal vaccines resulted in the development of numerous new vaccines.

For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 for prevention against infectious bronchitis virus (IBV) in animals.

Browse More Details@ https://www.futuremarketinsights.com/reports/companion-animal-vaccines-market

Know More About Companion Animal Vaccines Market Report

Future Market Insight provides a comprehensive research report on forecast revenue growth at the global, regional, and country levels, as well as an analysis of the most recent industry trends in each sub-segment from 2014 to 2029.

The global companion animal vaccines market is segmented in depth to cover every aspect of the market and provide the reader with a comprehensive market intelligence approach.

The study offers compelling insights into the companion animal vaccines market across seven major regions based on product type (attenuated live vaccines, conjugated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines), species type (canine, avian, feline), and distribution channel (companion animal hospitals, companion animal hospitals, companion animal research institutes).

Segmented 

Product

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

Species

• Canine
• Avian
• Feline

Distribution Channel

• Veterinary Clinics
• Veterinary Hospitals
• Veterinary Research Institutes
• Retail Pharmacies